This inventor holds 23 USPTO granted patents and 18 published patent applications and 10 EPO patents, primarily in Cystic Fibrosis Treatment. Top assignees: Vertex Pharmaceuticals, Inc., University of Virginia Patent Foundation, Wyeth. Active years: 2011-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- New City, NY (US) (2011)
- San Diego, CA (US) (2017 - 2024)
Company Filing History:
21 out of 1,168 
1 out of 1,045 
1 out of 1,309 
Years Active: 2011-2026
Areas of Expertise:
Title: The Innovations of Jeremy J. Clemens: A Pioneer in Cystic Fibrosis Research
Introduction: Jeremy J. Clemens, based in San Diego, CA, is an accomplished inventor with a remarkable portfolio of 18 patents focused on advancing treatments for cystic fibrosis. His work has significantly contributed to the pharmaceutical industry, specifically through his innovations at Vertex Pharmaceuticals, Inc.
Latest Patents: Among Jeremy's latest patents are groundbreaking disclosures regarding modulators of the cystic fibrosis transmembrane conductance regulator (CFTR). These patents reveal pharmaceutical compositions that include at least one modulator and outline methods for treating cystic fibrosis utilizing these innovative compositions. Additionally, he is credited with patents covering crystalline forms of CFTR modulators, including pharmaceutically acceptable salts and their solvates and hydrates. These patents also discuss methods for treating cystic fibrosis and processes for producing these modulators.
Career Highlights: Jeremy's career has been marked by his significant contributions to cystic fibrosis research. His role at Vertex Pharmaceuticals, Inc. has allowed him to collaborate closely with other industry leaders, leading to important advancements in treatment options for patients suffering from this debilitating illness.
Collaborations: Throughout his career, Jeremy has worked alongside noted scientists and innovators, such as Jinglan Zhou and Mark Thomas Miller. These collaborations have proven essential in enhancing the efficiency and effectiveness of the pharmaceutical compositions developed under his patents.
Conclusion: Jeremy J. Clemens's dedication to innovation in the field of cystic fibrosis treatment exemplifies the spirit of discovery and advancement in healthcare. His notable contributions and patents mark him as a leading figure in the pharmaceutical industry, continually pushing the boundaries of science to improve lives.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile